Skip to main content

Dr. Ha is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ha's full profile

Already have an account?

  • Office

    751 S Bascom Ave
    San Jose, CA 95128

Education & Training

  • Santa Clara Valley Medical Center
    Santa Clara Valley Medical CenterResidency, Internal Medicine, 2020 - 2023
  • Eastern Virginia Medical School
    Eastern Virginia Medical SchoolClass of 2020

Certifications & Licensure

  • American Board of Internal Medicine Internal Medicine

Press Mentions

  • CG Oncology Presents Preliminary Phase 2 Data with CG0070 in Combination with KEYTRUDA® (Pembrolizumab) in Non-Muscle-Invasive Bladder Cancer Unresponsive to Bacillus Calmette-Guerin
    CG Oncology Presents Preliminary Phase 2 Data with CG0070 in Combination with KEYTRUDA® (Pembrolizumab) in Non-Muscle-Invasive Bladder Cancer Unresponsive to Bacillus Calmette-GuerinNovember 13th, 2021
  • Enzychem Lifesciences Selected to Participate at the 15th New York Health Forum: Investing in Space - Next Frontier of Healthcare
    Enzychem Lifesciences Selected to Participate at the 15th New York Health Forum: Investing in Space - Next Frontier of HealthcareMarch 11th, 2021
  • JW Therapeutics Acquires Syracuse Biopharma and License to Eureka Therapeutics’ Solid Tumor Technology in China
    JW Therapeutics Acquires Syracuse Biopharma and License to Eureka Therapeutics’ Solid Tumor Technology in ChinaJuly 20th, 2020